Efficacy of CT screening for lung cancer in never-smokers: Analysis of Japanese cases detected using a low-dose CT screen

Lung Cancer

Volumn 74, Issue 3, 2011, Pages 426-432

  Kondo, Ryoichi ^a   Yoshida, Kazuo ^a   Kawakami, Satoshi ^a   Shiina, Takayuki ^a   Kurai, Makoto ^a   Takasuna, Keiichiro ^a   Yamamoto, Hiroshi ^a   Koizumi, Tomonori ^a   Honda, Takayuki ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chest; Computed tomography; Japanese; Lung cancer; Never smoker; Screening; X ray

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; JAPANESE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SMOKING; SURVIVAL RATE;

ADENOCARCINOMA; AGED; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 80755132154     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.05.006     Document Type: Article

References (42)

1. Jett J.R., Midthun D.E. Commentary: CT screening for lung cancer-caveat emptor. Oncologist 2008, 13(4):439-444.
2. Dubey S., Powell C.A. Update in lung cancer 2007. Am J Respir Crit Care Med 2008, 177(9):941-946.
3. Fontana R.S., Sanderson D.R., Woolner L.B., Taylor W.F., Miller W.E., Muhm J.R., et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer 1991, 67(4 Suppl.):1155-1164.
4. Melamed M.R., Flehinger B.J., Zaman M.B., Heelan R.T., Perchick W.A., Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest 1984, 86(1):44-53.
5. Levin M.L., Tockman M.S., Frost J.K., Ball W.C. Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report. Recent Results Cancer Res 1982, 82:138-146.
6. Black W.C. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 2007, 110(11):2370-2384.
7. van Iersel C.A., de Koning H.J., Draisma G., Mali W.P., Scholten E.T., Nackaerts K., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120(4):868-874.
8. Church T.R. Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol 2003, 10(6):713-715.
9. van den Bergh K.A., Essink-Bot M.L., Bunge E.M., Scholten E.T., Prokop M., van Iersel C.A., et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008, 113(2):396-404.
10. Patz E.F., Caporaso N.E., Dubinett S.M., Massion P.P., Hirsch F.R., Minna J.D., et al. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. J Thorac Oncol 2010, 5(10):1502-1506.
11. Kim T.J., Goo J.M., Lee K.W., Park C.M., Lee H.J. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule. Lung Cancer 2009, 64(2):171-178.
12. Nawa T., Nakagawa T., Kusano S., Kawasaki Y., Sugawara Y., Nakata H. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest 2002, 122(1):15-20.
13. Kaneko M., Eguchi K., Ohmatsu H., Kakinuma R., Naruke T., Suemasu K., et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996, 201(3):798-802.
14. Sone S., Takashima S., Li F., Yang Z., Honda T., Maruyama Y., et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998, 351(9111):1242-1245.
15. Bach P.B., Jett J.R., Pastorino U., Tockman M.S., Swensen S.J., Begg C.B. Computed tomography screening and lung cancer outcomes. JAMA 2007, 297(9):953-961.
16. Diederich S., Wormanns D., Semik M., Thomas M., Lenzen H., Roos N., et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002, 222(3):773-781.
17. Sobue T., Suzuki T., Fujimoto I., Matsuda M., Doi O., Mori T., et al. Case-control study for lung cancer and cigarette smoking in Osaka, Japan: comparison with the results from Western Europe. Jpn J Cancer Res 1994, 85(5):464-473.
18. Marugame T., Sobue T., Satoh H., Komatsu S., Nishino Y., Nakatsuka H., et al. Lung cancer death rates by smoking status: comparison of the Three-Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USA. Cancer Sci 2005, 96(2):120-126.
19. Marugame T., Hirabayashi Y. Comparison of time trends in lung cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol 2009, 39(10):696-697.
20. Cardenas V.M., Thun M.J., Austin H., Lally C.A., Clark W.S., Greenberg R.S., et al. Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study. II. Cancer Causes Control 1997, 8(1):57-64.
21. Thun M.J., Heath C.W. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med 1997, 26(4):422-426.
22. Thun M.J., Hannan L.M., Adams-Campbell L.L., Boffetta P., Buring J.E., Feskanich D., et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 2008, 5(9):e185.
23. Li F., Sone S., Abe H., MacMahon H., Doi K. Low-dose computed tomography screening for lung cancer in a general population: characteristics of cancer in non-smokers versus smokers. Acad Radiol 2003, 10(9):1013-1020.
24. Noguchi M., Morikawa A., Kawasaki M., Matsuno Y., Yamada T., Hirohashi S., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75(12):2844-2852.
25. Sone S., Nakayama T., Honda T., Tsushima K., Li F., Haniuda M., et al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer 2007, 56(2):207-215.
26. Sone S., Li F., Yang Z.G., Takashima S., Maruyama Y., Hasegawa M., et al. Characteristics of small lung cancers invisible on conventional chest radiography and detected by population based screening using spiral CT. Br J Radiol 2000, 73(866):137-145.
27. Henschke C.I., McCauley D.I., Yankelevitz D.F., Naidich D.P., McGuinness G., Miettinen O.S., et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999, 354(9173):99-105.
28. Smith J.J., Berg C.D. Lung cancer screening: promise and pitfalls. Semin Oncol Nurs 2008, 24(1):9-15.
29. Henschke C.I., Yankelevitz D.F., Libby D.M., Pasmantier M.W., Smith J.P., Miettinen O.S. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355(17):1763-1771.
30. Sagawa M., Tsubono Y., Saito Y., Sato M., Tsuji I., Takahashi S., et al. A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer 2001, 92(3):588-594.
31. Tsukada H., Kurita Y., Yokoyama A., Wakai S., Nakayama T., Sagawa M., et al. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study. Br J Cancer 2001, 85(9):1326-1331.
32. Nishii K., Ueoka H., Kiura K., Kodani T., Tabata M., Shibayama T., et al. A case-control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer 2001, 34(3):325-332.
33. Sagawa M., Nakayama T., Tsukada H., Nishii K., Baba T., Kurita Y., et al. The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan. Lung Cancer 2003, 41(1):29-36.
34. Kubik A., Polak J. Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer 1986, 57(12):2427-2437.
35. Aberle D.R., Adams A.M., Berg C.D., Clapp J.D., Clingan K.L., Gareen I.F., et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 2010, 102(23):1771-1779.
36. Aberle D.R., Berg C.D., Black W.C., Church T.R., Fagerstrom R.M., Galen B., et al. The National Lung Screening Trial: overview and study design. Radiology 2011, 258(1):243-253.
37. Sholl L.M., Yeap B.Y., Iafrate A.J., Holmes-Tisch A.J., Chou Y.P., Wu M.T., et al. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Res 2009, 69(21):8341-8348.
38. Yang C.H. EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future. Lung Cancer 2008, 60(Suppl. 2):S23-S30.
39. Bencardino K., Manzoni M., Delfanti S., Riccardi A., Danova M., Corazza G.R. Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. Intern Emerg Med 2007, 2(1):3-12.
40. Buttitta F., Barassi F., Fresu G., Felicioni L., Chella A., Paolizzi D., et al. Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. Int J Cancer 2006, 119(11):2586-2591.
41. Shigematsu H., Gazdar A.F. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006, 118(2):257-262.
42. Huang S.F., Liu H.P., Li L.H., Ku Y.C., Fu Y.N., Tsai H.Y., et al. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res 2004, 10(24):8195-8203.